EMEA-000774-PIP01-09-M03

Key facts

Invented name
Eviplera
Active substance
  • emtricitabine
  • Rilpivirine (hydrochloride)
  • Tenofovir (disoproxil fumarate)
Therapeutic area
Infectious diseases
Decision number
P/0274/2018
PIP number
EMEA-000774-PIP01-09-M03
Pharmaceutical form(s)
Film-coated tablet
Condition(s) / indication(s)
Treatment of human immunodeficiency virus (HIV-1) infection
Route(s) of administration
Oral use
Contact for public enquiries
Gilead Sciences International Ltd

Tel. +44 (0)1223 897300
E-mail: regulatory.pip@gilead.com

Decision type
W: decision granting a waiver in all age groups for all conditions/indications

Decision

How useful was this page?

Add your rating